878101P

C17 Lyso PAF

Avanti Research^™ - A Croda Brand 878101P, powder

• Synonym(e): 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₂₅H₅₄NO₆P
• CAS-Nummer: 111858-52-7
• Molekulargewicht: 495.67
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 10 mg (878101P-10mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 878101P
• Lipid-Typ: bioactive lipids; phosphoglycerides
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCCC

Beschreibung

Allgemeine Beschreibung

C17 Lyso PAF, also known as 1-O-heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine, is a precursor and metabolite of 1-O-heptadecyl-2-acetyl-sn-glycero-3-phosphocholine (C17:0 PAF). Lyso-platelet activating factor (PAF) is synthesized from PAF acetylhydrolases by the degradation of PAF. It is also synthesized from 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine (1-alkyl-phosphatidylcholine; PC) by the enzyme phospholipase A2 via the remodeling pathway.

Verpackung

5 mL Amber Glass Screw Cap Vial (878101P-10mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3